Quoin Pharmaceuticals, Ltd.
QNRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $5 | $5 | $0 |
| - Cash | $2 | $2 | $4 | $4 |
| + Debt | $0 | $0 | $3 | $3 |
| Enterprise Value | – | $4 | $4 | -$1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$4 | -$4 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$4 | -$4 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -6.71 | -6.28 | -6.5 | -12.41 |
| % Growth | -6.8% | 3.4% | 47.6% | – |
| Operating Cash Flow | -$2 | -$4 | -$3 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$4 | -$3 | -$2 |